A Day Up For Sienna Biopharmaceuticals, Inc.
Tue, Dec 24, 2019 at 05:30 PM
Sienna Biopharmaceuticals, Inc. (SNNA:NASDAQ) shot up at $0.14, representing a gain of 30.7%. The stock got featured on our News Catalysts scanner on Fri 13 Dec 19 at 12:16 PM in the 'RECOMMENDATION' category. From Tue 03 Dec 19, the stock recorded 28.57% Up Days and 46.67% Green Days
About Sienna Biopharmaceuticals, Inc. (SNNA:NASDAQ)
Sienna Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on bringing innovations in biotechnology to the discovery, development and commercialization of targeted, topical products in medical dermatology and aesthetics.
Top 10 Gainers:
- Microbot Medical Inc. (MBOT:NASDAQ), 61.03%
- Proteostasis Therapeutics, Inc. (PTI:NASDAQ), 51.01%
- CLPS Incorporation (CLPS:NASDAQ), 46.12%
- Lineage Cell Therapeutics, Inc. (LCTX:NYSEMKT), 34.52%
- TMSR Holding Company Limited (TMSR:NASDAQ), 33.33%
- Sienna Biopharmaceuticals, Inc. (SNNA:NASDAQ), 30.7%
- Soleno Therapeutics, Inc. (SLNO:NASDAQ), 28.57%
- Cassava Sciences, Inc. (SAVA:NASDAQ), 26.74%
- Hi-Crush Inc. (HCR:NYSE), 26.25%
- Applied Genetic Technologies Corporation (AGTC:NASDAQ), 23.98%